Neuralight

AI-based neurological evaluation and assessment tool for diagonosis

placeSan Francisco, California, United States calendar_todayFounded 2021 groups43 employees language neuralight.ai

Registered entities

Innovation

6 patent families (5 granted) — focus: Physics & computing, Human necessities; filing pace accelerating. Cited 1,628 times.

YearFilings
20221
20244
20255
20262

Social engagement

Social engagement: 7.6K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include Koch Disruptive Technologies.

Investor typeCountShare
Venture capital1158%
Angel & family office15%
Other / undisclosed737%

Recent activity

17 Jun 2026
Recognition
9 Jun 2026
Event
BIO 2026
7 Jun 2026
Partnership
Kariya Pharmaceuticals
Coming soon